Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]

Additional Metadata
Persistent URL	doi.org/10.1016/j.clim.2013.11.001, hdl.handle.net/1765/52421
Journal	Clinical Immunology
Organisation	Department of Pediatrics
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Allard, S. D., de Keersmaecker, B., de Goede, A., Verschuren, E., Koetsveld, J., Reedijk, M., Wylock, C., de Bel, A., Vandeloo, J., Pistoor, F., Heirman, C., Beyer, W., Eilers, P., Corthals, J., Padmos, I., Thielemans, K., Osterhaus, A., Lacor, P., van der Ende, M., … Gruters, R. (2014). Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]. Clinical Immunology, 150(1), 88–89.https://doi.org/10.1016/j.clim.2013.11.001

Publication